Granules India gets USFDA tentative nod for generic ADHD treatment tablets

[ad_1] New Delhi: Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health regulator for its generic amphetamine extended-release tablets indicated for treatment of attention deficit hyperactivity disorder, with eligibility of 180-day exclusivity. The tentative approval by the US Food and Drug Administration (USFDA) is for…

Read More

Weight-loss drugs: Indian giants Dr Reddy’s to Macleods start preparing for Ozempic patent expiry

[ad_1] Indian firms that make active pharmaceutical ingredients, or APIs, are gearing up to supply the basic ingredient that goes in making copies of Novo Nordisk A/S’s weight-loss drugs that are losing patent protection next year in several large markets. From local giants Dr Reddy’s Laboratories Ltd. to suppliers like Macleods Pharmaceuticals Ltd., Indian firms…

Read More